Showing results (111-120 of 164) with videos related to
Sort By:
Pageof 17
Lancet (London, England)|April 10, 2012
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 studySylvie Castaigne, Cécile Pautas, Christine Terré, et al.Leukemia|June 24, 2025
Comparison of induction with arsenic trioxide or chemotherapy in a real-world cohort of patients with high-risk acute promyelocytic leukemiaDelphine Lebon, Audrey Da Rocha, Bruno Cassinat, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2017
Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With NPM1 Mutation: A Study by the Acute Leukemia French Association GroupMarie Balsat, Aline Renneville, Xavier Thomas, et al.Leukemia Research|January 16, 2017
Immune stimulation during chemotherapy increases incidence of acute graft versus host disease in acute myeloid leukemia: A study on behalf of SFGM-TC and ALFALining Wang, Emmanuel Raffoux, Xavier Thomas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2015
Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 StudyStéphane Lepretre, Aurore Touzart, Thomas Vermeulin, et al.The Journal of Experimental Medicine|April 7, 2010
Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemiaCeline Callens, Séverine Coulon, Jerome Naudin, et al.Leukemia Research|January 27, 2009
When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group)Bruno Cassinat, Stéphane de Botton, Charikleia Kelaidi, et al.Blood|January 17, 2013
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemiaEric Jourdan, Nicolas Boissel, Sylvie Chevret, et al.Leukemia|February 21, 2020
Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative StudySabine Kayser, Ramy Rahmé, David Martínez-Cuadrón, et al.British Journal of Haematology|July 25, 2019
Genotype/phenotype correlations of childhood-onset congenital sideroblastic anaemia in a European cohortCyrielle Fouquet, Marie-Amelyne Le Rouzic, Thierry Leblanc, et al.Pageof 17